Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients.
Skin rash is a well-known predictive marker of the response to cetuximab (Cmab) in metastatic colorectal cancer (mCRC). However, the mechanism of skin rash development is not well understood. Following exposure to EGFR-targeted therapies, changes in IL-8 levels have been reported. The aim of this st...
Hlavní autoři: | , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Public Library of Science (PLoS)
2022-01-01
|
Edice: | PLoS ONE |
On-line přístup: | https://doi.org/10.1371/journal.pone.0276497 |